Search

everythinglearnresearchcommunity

for

Search:↓

Human hair follicle cells can help regenerate hair and reduce inflammation, aiding in hair loss treatment.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Dupilumab can cause unexpected scalp issues, so early symptom recognition is important to avoid hair loss.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

Targeting specific cell interactions may help treat skin fibrosis.

Autoimmune Polyendocrine Syndromes involve specific combinations of autoimmune diseases.

Psoriasis patients have immune cells that respond more strongly to signals and stimuli due to an intrinsic cellular defect.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Dendritic cells help regulate skin development and hair growth in mice.

Patients with Shwachman-Diamond syndrome often get misdiagnosed due to a wide range of symptoms, including immune system problems and bone abnormalities.

DCPA is a chronic skin condition affecting the lower limbs, mainly in men, with unclear causes and treatments that often don't work well.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

EPDS and MS might share an immune-related cause.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.